AxoGen (AXGN) Receives a Buy from JMP Securities
20 July 2022 - 05:35AM
TipRanks
In a report released today, David Turkaly from JMP Securities
maintained a Buy rating on AxoGen (AXGN – Research Report), with a
price target of $20.00. The company's shares closed last Tuesday at
$9.06, close to its 52-week low of $6.87. According to
TipRanks.com, Turkaly is a 3-star analyst with an average return of
2.5% and a 42.4% success rate. Turkaly covers the Healthcare
sector, focusing on stocks such as Zimmer Biomet Holdings, Integra
Lifesciences, and OrthoPediatrics. AxoGen has an analyst consensus
of Strong Buy, with a price target consensus of $19.00,
representing a 125.7% upside.
https://www.tipranks.com/news/blurbs/axogen-axgn-receives-a-buy-from-jmp-securities-2?utm_source=advfn.com&utm_medium=referral
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Nov 2023 to Dec 2023
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Dec 2022 to Dec 2023
